基于微生物组的产品:对于炎症性皮肤疾病的治疗潜力
Anamarija Rušanac1,2, Zara Škibola1,2, Mario Matijašić1,2
1Department of Intercellular Communication, Center for Translational and Clinical Research, School of Medicine, University of Zagreb, Šalata 2, 10000 Zagreb, Croatia.
International journal of molecular sciences
|July 29, 2025
概括
保持健康的皮肤微生物群是皮肤健康的关键. 基于微生物组的干预措施,如益生菌,有望通过恢复微生物平衡来管理炎症性皮肤疾病.
科学领域:
- 皮肤病学和微生物学
- 研究皮肤微生物组在健康和疾病中的作用.
背景情况:
- 皮肤微生物群的平衡对皮肤健康至关重要.
- 功能失调或微生物不平衡与炎症性皮肤疾病有关,如亚托皮炎,,牛皮和粉红疹.
- 测序技术的进步提高了对皮肤微生物群落的理解.
研究的目的:
- 探索基于微生物组的干预措施在管理炎症性皮肤疾病方面的潜力.
- 突出针对皮肤生态系统的新型治疗策略.
主要方法:
- 使用高通量测序和元基因组分析来研究皮肤微生物群落.
- 审查当前和新兴的基于微生物组的治疗方法.
主要成果:
- 基于微生物组的产品 (益生菌,益生菌,后生菌,活生物疗法) 提供针对性调节皮肤生态系统.
- 这些干预措施可以增强有益的微生物,抑制病原体,改善免疫耐受性.
- 显示了预防,管理和潜在地逆转炎症性皮肤疾病的潜力.
结论:
- 基于微生物组的策略代表了炎症性皮肤疾病的有希望的治疗途径.
- 需要进一步的研究,临床验证和监管框架才能充分发挥其潜力.
- 这些新的方法为传统疗法提供了有针对性的替代方案,有可能减少副作用和耐药性.
相关概念视频
Microorganisms in Medicine and Therapeutics
345
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
345
Inflammatory Bowel Disease IV: Pharmacological Management
193
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
193
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
235
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
235
Inflammatory Response
7.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
7.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
Drugs for Treatment of Ulcerative Colitis in IBD
239
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
239


